Skip to content
naulon
Not checkedNot checked for notices yet.

Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis

Jéssica A. Barbosa, Lucas A. Rodrigues, Daniel A. Columbus and 4 more

Porcine Health Management · 2021

doi:10.1186/s40813-021-00228-9 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea. This study investigated the usefulness of fecal calprotectin as a biomarker of intestinal inflammation in Brachyspira hyodysenteriae and Salmonella Typhimurium infected pigs. Results Fecal samples from pigs with colitis ( n = 18) were collected from animals experimentally inoculated with B. hyodysenteriae ( n = 8) or from sham-inoculated controls ( n = 3). Fecal samples from pigs with enteritis ( n = 14) were collected from animals inoculated with Salmonella enterica serovar Typhimurium ( n = 8) or from sham-inoculated controls ( n = 4). For both groups, fecal samples were scored as: 0 = normal; 1 = soft, wet cement; 2 = watery feces; 3 = mucoid diarrhea; and 4 = bloody diarrhea. Fecal calprotectin levels were assayed using a sandwich ELISA, a turbidimetric immunoassay and a point-of-care dipstick test. Fecal calprotectin levels were greater in colitis samples scoring 4 versus ≤ 4 using ELISA, and in feces scoring 3 and 4 versus ≤ 1 using immunoturbidimetry ( P < 0.05). No differences were found in calprotectin concentration among fecal scores for enteritis samples, regardless of the assay used. All samples were found below detection limits using the dipstick method. Conclusions Fecal calprotectin levels are increased following the development of colitis, but do not significantly change due to enteritis. While practical, the use of commercially available human kits present sensitivity limitations. Further studies are needed to validate the field application of calprotectin as a marker of intestinal inflammation.

Abstract licence: CC BY

References59

    40 more references, whose wording the paper’s licence keeps private.

    All 59 references

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.